CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Michael C O'Donovan

OPENALEX: A5059458620↗ORCID: 0000-0001-7073-2379↗

Affiliations

Organizations

Cardiff Universityauthorship · GB King's College Londonauthorship · GB Maastricht Universityauthorship · NL National Institute for Health and Care Researchauthorship · GB South London and Maudsley NHS Foundation Trustauthorship · GB

Public evidence

6 connected articles

Identifying and Characterising Common Genetic Differences in Schizophrenia and Bipolar Disorder2026 · medRxiv Methylomic signature of current cannabis use in two first-episode psychosis cohorts.2025 · Europe PMC The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.2024 · Europe PMC The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.2023 · Europe PMC The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.2021 · PubMed Central Open Access Complement system biomarkers in first episode psychosis.2019 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Michael C O'Donovan - Medical Cannabis Research Engine